Tokyo Cancer Clinic: 5th Generation Multivalent Dendritic Cell Vaccine (ABeVax) and Photoimmunotherapy
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
Director tokyo
Located in Chiyoda-ku, Tokyo, Tokyo Cancer Clinic is a premier facility led by Dr. Hiroyuki Abe, a Japanese authority on immunotherapy. The clinic is not only a developer of technology but also a practitioner of personalized precision anti-cancer nurturing care.
ABeVax: 5th Generation Dendritic Cell Vaccine
The ABeVax technology developed by Dr. Abe's team marks a significant breakthrough in dendritic cell therapy:
- Multivalent Attack: Unlike single-antigen vaccines, ABeVax can simultaneously target multiple tumor markers, preventing cancer cells from escaping through mutation.
- Minimal Blood Volume: High-quality vaccines can be produced from just approximately 25ml of blood, significantly reducing the physical burden on patients in advanced stages.
- Patented Process: Exclusive cell activation technology ensures that reinfused dendritic cells possess the strongest antigen-presenting capabilities.
Near-Infrared Photoimmunotherapy (PIT)
The clinic has also introduced the latest Photoimmunotherapy:
- Precision Tagging: Patients are injected with light-sensitive antibody drugs that precisely attach to the surface of cancer cells.
- Physical Destruction: Exposure to specific wavelengths of near-infrared light causes cancer cells to burst instantly, releasing large amounts of tumor antigens.
- Synergistic Effect: These released antigens are immediately captured by the ABeVax-activated immune system, triggering a systemic immune response.
Why Choose Tokyo Cancer Clinic?
- Authoritative Leadership: Dr. Hiroyuki Abe enjoys a high international reputation in immunology and is committed to establishing a comprehensive personalized medical system.
- Prime Location: Located in Kudanshita, the clinic offers a dignified environment near Tokyo's core business districts, providing great convenience for medical itineraries.
- Medical Evidence: All therapies are based on rigorous clinical data, with results constantly updated at international academic conferences.
【Medical Supporter Guardian Statement】 Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.